Preliminary experience with amlodipine in the pediatric population

American Journal of Therapeutics

Volumn 13, Issue 3, 2006, Pages 198-204

  Andersen, Jeffrey ^a   Groshong, Ted ^a   Tobias, Joseph D ^a  

^a University of Missouri   (United States)

Author keywords

Amlodipine; Calcium channel antagonist; Hypertension

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ISRADIPINE; NICARDIPINE; NIFEDIPINE;

ADOLESCENT; ADULT; ANKLE EDEMA; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; HYPOTENSION; INDUCED HYPOTENSION; MALE; NAUSEA; PREDICTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TREATMENT WITHDRAWAL; VOMITING;

ADOLESCENT; ADULT; AMLODIPINE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTENSION; MALE; PEDIATRICS; RETROSPECTIVE STUDIES;

EID: 33745821213     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000147593.73888.d5     Document Type: Article

References (17)

1. Sinaiko AS, Gomez-Marin O, Prineas RJ. Significant diastolic hypertension in pre-high school black and white children: the children and adolescent blood pressure program. Am J Hypertens. 1988;1:178-180.
2. Hanna JD, Chan JCM, Gill JR Jr. Hypertension and the kidney. J Pediatr. 1991;118:327-340.
3. Strauser LM, Groshong T, Tobias JD. Initial experience with isradipine for the treatment of hypertension in children. South Med J. 2000;93:287-293.
4. Tobias JD, Lowe S, Deshpande JK. Nicardipine: peri operative applications. Paediatr Anaesth. 1995;5:171-176.
5. Murdoch D, Heel R. Amlodipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in cardiovascular disease. Drugs. 1991;41:478-505.
6. Abernethy D. The pharmacokinetic profile of amlodipine. Am Heart J. 1989;118:1100-1103.
7. Reid JI, Meredith PA, Donnelly R, et al. Pharmacokinetics of calcium antagonists. J Cardiavasc Pharmacol. 1988;12(Suppl 7):S22-S26.
8. Hwang YS, Yen HW. Amlodipine - once-daily monotherapy in systemic hypertension. Am J Cardiol. 1994;73:1230-1232.
9. Islim IF, Watson RD, Ihenacho HNC, et al. Amlodipine: effective for treatment of mild to moderate essential hypertension and left ventricular hypertrophy. Cardiology. 2001;96(Suppl 1):10-18.
10. Östergren J, Isaksson H, Brodin U, et al. Effect of amlodipine versus felodipine extended release on 24 hour ambulatory blood pressure in hypertension. Am J Hypertens. 1998;11:690-696.
11. Flynn JT, Smoyer WE, Bunchman TE. Treatment of hypertensive children with amlodipine. Am J Hypertens. 2000;13:1061-1066.
12. Tallian KB, Nahata MC, Turman MA, et al. Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol. 1999;13:304-310.
13. Khattak S, Rogan JW, Saunders EF, et al. Efficacy of amlodipine in pediatric bone marrow transplant patients. Clin Pediatr. 1998;37:31-35.
14. Pfammatter JP, Clericetti-Affolter C, Truttmann AC, et al. Amlodipine once-daily in systemic hypertension. Eur J Pediatr. 1998;157:618-621.
15. Rogan JW, Lyszkiewicz DA, Blowey D, et al. A randomized prospective crossover trial of amlodipine inipediatric hypertension. Pediatr Nephrol. 2000;14:1083-1087.
16. Nahata MC, Morosco RS, Hipple TF. Stability of amlodipine besylate in two liquid dosage forms. J Am Pharm Assoc. 1999;39:375-377.
17. Lyazkiewicz DA, Levichek Z, Kozer E, et al. Bioavailability of a pediatric amlodipine suspension. Pediatr Nephrol. 2003;18:675-678.